To determine a role of Fra-1 in CD44 expression, we next developed a shFra-1 construct and verified in both an SV40+ and SV40- MM line that CD44 expression was reduced (Figure 4A). This evidence concerns the gene FOSL1 and Miyoshi myopathy.